Fig. 2c A case of infantile onychomycosis cured by 5% amorolfine nail lacquer Chen Shuang 1, RAN Yuping 1*, Dai Yalin 2, Jebina Lama 1, Hu Wenying 1 1.

Slides:



Advertisements
Similar presentations
The field of Podiatry specializes in the following areas:
Advertisements

Welcome to A Day of Derm for GPs, thank you so much for joining us today in Ajax (you may want to add something related to the weather ie. Thank you fo.
Tuberculosis in Children: Prevention Module 10C - March 2010.
Poster will be available at after September 10 th 2006 ABSTRACT AN2690 is a new novel antifungal being developed for the treatment of onychomycosis.
Prof. Khaled H. Abu-Elteen
PROBLEMS OF ASTHMA MANAGEMENT IN PAKISTAN. BURDEN OF ASTHMA ASTHMA IS ONE OF THE MOST COMMON CHRONIC DISEASE WORLDWIDE PREVALENCE INCREASING IN MANY COUNTRIES.
Antimicrobial Resistance in N. gonorrhoeae: In Brief 2014 INTRODUCTION Increased action is needed to help prevent and control gonorrhea. Worldwide antimicrobial.
Is a Ringworm Infection Really Caused by a Worm?
Mucor irregularis infection around the inner canthus cured by amphotericin B KANG Daoxian 1, WAN Huiying 2, RAN Yuping 1*, JIANG Xian 1, HAO Dan 1 1. Department.
SORE THROAT & OTITIS MEDIA
Lab-6- Fungi in Tissue.
Treatments for Autism Spectrum Disorder Autism Case Training: A Developmental-Behavioral Pediatrics Curriculum 1 Authors Cristina Farrell, MD, Children’s.
Podiatry and the treatment of Rheumatoid Arthritis
Oropharyngeal Candidiasis in Patients with AIDS
MIDICAL MYCOLOGY LAP 2 NAJLA AL-ALSHAIKH.
Chapter 1: An Overview of the HIV/AIDS Epidemic Module 1, Chapter 1.
Microbiology Chapter 48 Cutaneous mycoses Prepared by: Mohammad Yousef Al-Najjar Mohammad Yousef Al-Najjar Presented to: Dr.Abdelraouf El-manama Faculty.
Start a new, blank presentation with a blank slide layout: File: New Blank presentation Choose an Autolayout: Blank The size of the slide will default.
Neonates (children less than one month of age) have immature immune systems and are at higher risk for serious complications of bacterial and viral infections,
Definition of epilepsy
Copyright © 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 40 Nursing Care of the Child With a Cardiovascular Disorder Maternity and.
Acute Stroke: Principles of Modern Management A program of the American Academy of Neurology The AAN Acute Stroke Management courses are supported in part.
Cutaneous Fungal Infections
According to a study by a research network supported by the National Institutes of Health, young men being treated for HIV are more likely to have low.
Flucoral capsules Product knowledge. Pharmacokinetics of fluconazole Distribution of Fluconazole is extensive and even throughout tissues. The high polarity.
PHPR 202: ANTIFUNGAL THERAPY Andrew Schmelz, PharmD Post-Doctoral Teaching Fellow Purdue University School of Pharmacy.
بسم الله الرحمن الرحيم Medical mycology LAB 9 Dalia Sarar.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Probiotic in Colic, Regurgitation, & Constipation Indrio F, Di Mauro A, Riezzo G,
DIABETES STORY LSSI Alum, 2009 Jennifer Muñoz, Del Mar Union School District.
Tinea Pedis Natural History & Clinical Trials Joseph Porres, M.D., Ph.D. Medical Officer, DDDDP.
Perspectives on Enhancing Consumer Outcomes with Topical Antifungals
GET SKIN HEALTH SMART! WHY SKIN HEALTH AS YOU AGE MATTERS 1.
HIV is the virus that causes AIDS, a disease that weakens the body’s immune system and may have fatal consequences.
Pharmacology and the Nursing Process in LPN Practice
Integrated Management of Childhood Illnesses
Public health impacts of donor screening for T. cruzi infection Susan P. Montgomery, DVM MPH Division of Parasitic Diseases Centers for Disease Control.
Diabetes: Challenges in the diagnosis and care of patients in the community Dr Oudone Family Medicine Specialist CME October 15-17, 2012 Pakse.
Clinical Pharmacy Lec:3
Molluscum Contagiosum Yazid Molluscum Contagiosum A self limited cutaneous infection caused by a large DNA poxvirus that affects both children.
1115 Waiver Proposals California Children’s Services Program.
Human Immune Deficiency Virus Infection Dr Huda Taha Sep 2015.
Beyond bacteria and viruses……. u Diverse group of heterotrophs.  Many are ecologically important saprophytes (consume dead and decaying matter)  Others.
STI/ STD Don’t Let it Happen to You By: Andrea Abrams Linda Dhennin Reshma Prasad Rachael Walker Sharon Wang.
PMDT IN CHINESE TAIPEI ECONOMY Anita Pei-Chun Chan, MD, PhD Medical Officer, TCDC Associated Director, TB Research Center, TCDC Assistant Professor, Institute.
Risk Factors for Candida dubliniensis Bloodstream Infections Katherine Veltman, B.S., Peggy L. Carver, Pharm.D, FCCP The University of Michigan Health.
Provider Initiated HIV Counseling and Testing Unit 1: Introduction to HIV/AIDS.
Denis G. Patterson, DO ECHO Project April 20, 2016 CDC Guidelines for Prescribing Opioids for Chronic Pain.
Shubhangi Arora1; Eden Haverfield2; Gabriele Richard2; Susanne B
HOMEOPATHY A RESEANABLE ALTERNATIVE TO HAIR AND SKIN DISORDERS BY DR.A.K.SRIVASTAVA, Ph.D,FICSI,FCABR DR.S.C.SRIVASTAVA, Ph.D, BMS DR.NIMANSHI SRIVASTAVA,
By: DR.Abeer Omran Consultant pediatric infectious disease
A case of severe psoriasis in an 1 year old baby
National Healthcare Science Week 2017
TRISOMY 18 aka EWARD’S SYNDROM
World Kidney Day 2016: Kidney Disease & Children
Dermatology Department
SYMPTOMS | CAUSES | DIAGNOSIS | TREATMENT
Copyright © 2004 American Medical Association. All rights reserved.
WHY SKIN HEALTH AS YOU AGE MATTERS
Introduction to Clinical Pharmacy
The Impact Of Pediatric Critical Illness, Injury, Complex Medical Conditions And Disabilities On Families Office of Rare Diseases and the National Institute.
Treating Hep C with Novel Agents
Clinical Trials.
Ask the Onychomycosis Expert, Part 2
Ask the Onychomycosis Expert, Part 1
How to Achieve Aggressive BP Goals in Difficult-to-Treat Patients
Before and After: Patient Cases in Onychomycosis
Severe Chronic Conditions Substantial Service Needs
Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from.
HUMAN IMMUNODEFICIENCY VIRUS (HIV) PREVENTION & CARE
Presentation transcript:

Fig. 2c A case of infantile onychomycosis cured by 5% amorolfine nail lacquer Chen Shuang 1, RAN Yuping 1*, Dai Yalin 2, Jebina Lama 1, Hu Wenying 1 1. Department of Dermatovenereology, 2. Department of Medical Laboratory, West China Hospital, Sichuan University *Corresponding author: Onychomycosis in infants is rare. Since none of the oral and topical antifungal agents are approved for the treatment of onychomycosis in infants, there are no monitoring guidelines for this age group. Here we report a case of infantile onychomycosis cured by 5% amorolfine nail lacquer without side effects. A 16-month-old boy in good health presented asymptomatic alterations in the toenails on he left foot, of approximately half year’s evolution. His mother had been diagnosised of onychomycosis 3 years ago without treatment. On examination, there were white patches on the surface of the third toenail to the fifth toenail, without any other alterations (Fig. 1a). Direct microscopic examination (with KOH) of superficial nail scrapings showed numerous spores (Fig. 2a). Fungal culture of nail scrapings revealed white filamentous colonies (Fig. 2b) which were identified as Trichophyton rubrum by little slide culture (Fig. 2c) and ITS1/4-PCR, sequence based molecular validation. A diagnosis of superficial white onychomycosis (SWO) by T. rubrum was made. The patient was treated with topical application of 5% amorolfine nail lacquer once a week in the first 12 weeks and once every two weeks in the following 12 weeks (Fig. 3). His lesions was completely cured after the end of treatment (Fig. 1b). There was no recurrence with half year follow-up. Onychomycosis is a relatively common disease accounting for up to 50% of all nail disorders [1]. The prevalence of onychomycosis rises with age. To our knowledge, infantile onychomycosis is rarely previously reported. Diabetes, psoriasis and other diseases may also increase the risk of infection [2-3]. In those health individuals who are affected, a family history of onychomycosis is not uncommon as our patient, giving importance to the examination of the whole family for fungal nail infections. It is well known how difficult it is to treat toe nail mycoses, especially when it happen to infants. The physician needs to evaluate the benefits and risks more carefully [4]. In our case, we report a case of infantile SWO associated with family history was successfully cured by 5% amorolfine nail lacquer in half year, which provides a therapeutic alternative to infantile onychomycosis, especially to this type. 1.Andre J, Achten G. Onychomycosis. Int J Dermatol. 1987;26:481–90. 2.Gupta AK, Chang P, Del Rosso JQ, et al. Onychomycosis in children: prevalence and management. Pediatr Dermatol. 1998;15: Peña-Penabad C, García-Silva J, Almagro M, et al. Superficial white onychomycosis in a 3-year-old human immunodeficiency virus- infected child. J Eur Acad Dermatol Venereol. 2001;15(1): Baran R, Kaoukhov A. Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J Eur Acad Dermatol Venereol. 2005;19(1):21-9. IntroductionDiscussion Diagnosis and treatment Case References Fig. 1a Fig. 2a KOH ×400Fig. 2b Fig. 1b Fig. 3 The time cross of 5% amorolfine nail lacquer administration (18 applications in total) No. of treatment Week